🚀 Cyclodextrins: Beyond Pharma! 🚀
From dietary supplements and cosmetics to energy, agriculture, and even space exploration, cyclodextrins are transforming industries in unexpected ways. 🌍✨
Curious about their potential? Tune into the podcast to explore the science and real-world applications of these versatile molecules! 🎧
Subscribe for updates and more episodes: (3) Season 2 – Episode 1 – cyclodextrins beyond pharma | LinkedIn
If there is a dream-team in cyclodextrin research, this author-crew might be the one.
By introducing this standardized nomenclature to the world of cyclodextrins, especially molecular modeling, we aim to enhance molecular design, improve reproducibility, and streamline both experimental and computational research in the CD field.
Special thanks to Angel Piñeiro and Rebeca Garcia-Fandino for the great concept, Amelia Anderson and Matthew “Oki” O’Connor (Cyclarity Therapeutics), J. D. Pipkin (Ligand Pharmaceuticals), Milo Malanga PhD, Milo, Tamas Sohajda (CarboHyde), Thorsteinn Loftsson (Oculis) and Lajos Szente (Cyclolab R&D Ltd.) for contributing.
At CarboHyde we really believe that cyclodextrins have much more to offer beyond the pharma industry and are testing the waters in new areas, like cosmetic applications.
We have a number of development projects in the area that we will share in the coming weeks.
In the meantime, you can meet Dani at Cosmoprof Worldwide Bologna if you wish to discuss how cyclodextrins are and can be used in cosmetics.
And also in daily training, 20 km walking is quite a leg-day 🙂
Gergely Toth and Tamas Kiss, participate at Health Tech Hub Styria (HTH) – Pitch & Partner 2025 in Graz establishing new connections with companies from our western neighbor.
The event aims to strengthen the connection between industry and academia and showcase early-stage innovations. It is also an excellent opportunity to find project partners, discuss future collaborations, and exchange experiences.
We appreciate the support of HEPA Hungarian Export Promotion Agency .
About the event: Health Tech Hub Styria 2025 – Home
I am thrilled to accept the invitation of Prof. Erem Bilensoy to deliver a talk at Hacettepe University about the pharma uses of cyclodextrins.
The department’s 2024-25 Spring Semester Seminars will be held between March 26, 2025 and May 28, 2025 on Wednesdays between 09:30-10:30 in the Seminar Hall of the Department of Pharmaceutical Technology. There is a free participation link for students, academicians, public employees and pharmaceutical industry members who want to follow the seminars online.
I hope many will be there and we will have a stimulating and active discussion!
One of the biggest problems to overcome with cyclodextrins?
Sustained release.
In this deck we show how we achieve this at CarboHyde, leveraging the synergistic advantages of cyclodextrin and other drug delivery technologies.
Do you have an active on the shelf to try this tool with?
I am happy to contribute to this fascinating upcoming event!
Join the International Conference on Recent Breakthroughs in Chemical Sciences (InnoChem-25) organized by the School of Sciences, Woxsen University.
🔬 Theme: Innovations in Chemistry for Sustainable Solutions
📅 April 8-11, 2025
🌐 Fully Online Conference
Featuring distinguished plenary speakers:
– Dr. Joe Wang (University of California San Diego, USA)
– Prof. Kara Bren (University of Rochester, USA)
– Dr. Tamas Sohajda (CarboHyde, Hungary)
– Dr. Tapas Sen, PhD, FRSC, FHEA, FRSM (University of Central Lancashire, UK)
Plus an impressive lineup of keynote speakers from renowned institutions worldwide, including experts from ICT Mumbai, IIT Hyderabad, Czech Republic, Nigeria, and more!
Perfect opportunity for:
• Chemical scientists
• Researchers
• Industry professionals
• Academia
Register now: REGISTRATION FEE ONLINE
Actually, it’s 103 already.
I started writing this newsletter on the 23rd January, 2023.
In the ever-evolving world of science, staying updated on the latest research of cyclodextrins can be a challenge. Cyclodextrin Tales, a LinkedIn-based scientific newsletter, has been bridging that gap by providing insightful articles on cyclodextrins—fascinating ring-shaped molecules with applications in pharmaceuticals, food, and beyond. Now, with its 100th issue, the blog has firmly established itself as a go-to resource for scientists, researchers, and industry professionals alike.
Launched to bring awareness and discussion around cyclodextrins, Cyclodextrin Tales has consistently delivered high-quality, engaging content. Each issue dives into a different aspect of these versatile molecules, from their role in drug delivery and environmental applications to emerging innovations in material science. The blog’s ability to break down complex scientific concepts into accessible insights has made it an essential read for both experts and newcomers to the field.
Beyond just being informative, Cyclodextrin Tales has cultivated a growing community of professionals who share a passion for these intriguing molecules, counting now 4500+ subscribers. Discussions sparked by each issue have led to collaborations, knowledge exchange, and deeper engagement within the scientific world. By reaching this 100th issue milestone, the blog not only marks a numerical achievement but also highlights the sustained curiosity and innovation surrounding cyclodextrins.
As Cyclodextrin Tales looks ahead to the future, it remains a valuable hub for scientific exploration. With new research constantly emerging, the blog is set to continue its mission of educating, inspiring, and connecting people in the world of cyclodextrins. Here’s to the next 100 issues and beyond!
Some of my favorite issues?
Size Matters: How Cyclodextrin Cavity Size Impacts its Applications
CarboHydrate Chronicles – the podcast to meet cyclodextrin experts
Exploring the Visionary Role: Ophthalmic Uses of Cyclodextrins
Beyond the Doughnut: Cyclodextrins as Nanoparticles in Cutting-Edge Innovations
What to Expect?
Explore the evolving landscape of cyclodextrin-based drug delivery, from established uses to groundbreaking innovations. Our expert speaker will dissect key advancements, addressing both challenges and transformative opportunities that enhance therapeutic efficacy.
Key Focus Areas:
Monoclonal Antibodies
Gene Therapy
Vaccines
Biotechnology
You can register here: Cyclodextrin Masterclass IV – CarboHyde
What a bright day for our company!
We have a new PhD among us, huge congratulations to Kristóf Felegyi (and maybe his wife, Csenge Anna Felegyi-Tóth :P) to a successful defense!
Summary of the PhD thesis:
The dissertation investigates the chemical composition and biological activities of Buglossoporus quercinus and Xylobolus subpileatus.
The findings suggest potential applications in cancer treatment and enzyme inhibition.
Also this means that now 50+% of our fantastic team has PhD! Not bad…
